CM
Caption Management Portfolio holdings
AUM
$1.09B
This Quarter Return
+2.82%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$919M
AUM Growth
+$919M
(+19%)
Cap. Flow
+$74.2M
Cap. Flow
% of AUM
8.07%
Top 10 Holdings %
Top 10 Hldgs %
42.78%
Holding
986
New
223
Increased
79
Reduced
100
Closed
195
Top Buys
| 1 |
Verizon
VZ
|
$96.4M |
| 2 |
Cytokinetics
CYTK
|
$33.8M |
| 3 |
Cigna
CI
|
$13.8M |
| 4 |
Marathon Petroleum
MPC
|
$9.86M |
| 5 |
Charter Communications
CHTR
|
$9.13M |
Top Sells
| 1 |
Lockheed Martin
LMT
|
$28.8M |
| 2 |
International Paper
IP
|
$26.8M |
| 3 |
American Tower
AMT
|
$18.5M |
| 4 |
Bristol-Myers Squibb
BMY
|
$18.4M |
| 5 |
On Holding
ONON
|
$14.8M |
Sector Composition
| 1 | Healthcare | 21.51% |
| 2 | Communication Services | 19.19% |
| 3 | Financials | 13.02% |
| 4 | Technology | 10.5% |
| 5 | Consumer Discretionary | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBCH
26
Turtle Beach Corporation Common Stock
TBCH
$294M
| $6.61M | 0.09% |
603,588
-99,725
| -14% | -$1.09M |
|
27
Intel
INTC
$105B
| $6.57M | 0.09% |
130,800
+92,800
| +244% | +$4.66M |
|
28
Ally Financial
ALLY
$12.6B
| $6.24M | 0.08% |
178,700
+125,700
| +237% | +$4.39M |
|
29
MetLife
MET
$53.6B
| $5.99M | 0.08% |
+90,596
| New | +$5.99M |
|
30
Procter & Gamble
PG
$370B
| $5.28M | 0.07% |
+36,000
| New | +$5.28M |
|
31
Exelixis
EXEL
$9.95B
| $5.22M | 0.07% |
217,514
+60,174
| +38% | +$1.44M |
|
32
Microchip Technology
MCHP
$34.2B
| $5.18M | 0.07% |
57,424
+17,424
| +44% | +$1.57M |
|
33
Pilgrim's Pride
PPC
$10.3B
| $5.04M | 0.07% |
182,332
+41,032
| +29% | +$1.13M |
|
34
iShares US Real Estate ETF
IYR
$3.7B
| $4.75M | 0.06% |
+52,000
| New | +$4.75M |
|
35
Marriott Vacations Worldwide
VAC
$2.69B
| $4.67M | 0.06% |
+55,000
| New | +$4.67M |
|
36
VanEck Gold Miners ETF
GDX
$19.6B
| $4.65M | 0.06% |
+150,000
| New | +$4.65M |
|
37
AbbVie
ABBV
$374B
| $4.6M | 0.06% |
29,700
+26,000
| +703% | +$4.03M |
|
38
MoonLake Immunotherapeutics
MLTX
$3.78B
| $4.53M | 0.06% |
75,000
+67,957
| +965% | +$4.1M |
|
39
ON Semiconductor
ON
$19.5B
| $4.27M | 0.06% |
51,125
+49,125
| +2,456% | +$4.1M |
|
40
Amicus Therapeutics
FOLD
$2.42B
| $4.25M | 0.06% |
299,500
+272,500
| +1,009% | +$3.87M |
|
41
Alnylam Pharmaceuticals
ALNY
$58.6B
| $4.12M | 0.06% |
21,542
-15,958
| -43% | -$3.05M |
|
42
Carvana
CVNA
$50B
| $4.1M | 0.06% |
+77,500
| New | +$4.1M |
|
43
Kenvue
KVUE
$39.2B
| $4.1M | 0.06% |
190,558
-171,232
| -47% | -$3.69M |
|
44
Carlisle Companies
CSL
$16B
| $4.06M | 0.05% |
+13,000
| New | +$4.06M |
|
45
Live Nation Entertainment
LYV
$37.6B
| $4.02M | 0.05% |
+43,000
| New | +$4.02M |
|
46
McDonald's
MCD
$226B
| $3.97M | 0.05% |
13,400
-1,000
| -7% | -$297K |
|
47
First Solar
FSLR
$21.6B
| $3.93M | 0.05% |
22,800
+8,480
| +59% | +$1.46M |
|
48
Sigma Lithium
SGML
$671M
| $3.87M | 0.05% |
122,629
-3,871
| -3% | -$122K |
|
49
Madison Square Garden
MSGS
$4.71B
| $3.8M | 0.05% |
20,904
+8,508
| +69% | +$1.55M |
|
50
Applovin
APP
$165B
| $3.77M | 0.05% |
94,655
+92,555
| +4,407% | +$3.69M |
|